Latest News & Updates of Loncom Pharma

Celebrating Shandong Loncom Pharmaceutical's Fezolinetant and Dotinurad Receiving WC Certificates

Shandong Loncom, proudly announces the launch of three high-potential star products: Abrocitinib, Ritlecitinib Mesylate, and Iptacopan (For Research Use Only).

Recently, the Biocom team traveled to Seoul, South Korea, to participate in CPHI Korea 2025, the World Pharmaceutical Ingredients Exhibition. During the event, the team engaged with global pharmaceutical industry leaders to explore collaborative opportunities.

Quitting smoking is one of the most impactful steps you can take for your health and well-being. However, the journey to becoming smoke-free is often challenging due to nicotine addiction and withdrawal symptoms. Fortunately, modern medicine offers effective aids to support this process, and Varenicline Tartrate has emerged as one of the leading prescription medications to help smokers quit successfully.